EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample

Ashraf Yaseen iD, Stacia M DeSantis, Rachit Sabharwal, Yashar Talebi iD, Michael D Swartz, Shiming Zhang, Luis Leon Novelo, Cesar L Pinzon-Gomez, Sarah E Messiah, Melissa Valerio-Shewmaker, Harold W Kohl, Jessica Ross und 4 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0303420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ashraf Yaseen und 15 weiteren Autor:innen. Beteiligte Einrichtung: The University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, TX, United States of America. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, SARS-CoV-2, Antibodies, Viral. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Texas Health and Human Services Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Studies indicate that individuals with chronic conditions and specific baseline characteristics may not mount a robust humoral antibody response to SARS-CoV-2 vaccines. In this paper, we used data from the Texas Coronavirus Antibody REsponse Survey (Texas CARES), a longitudinal state-wide seroprevalence program that has enrolled more than 90,000 participants, to evaluate the role of chronic diseases as the potential risk factors of non-response to SARS-CoV-2 vaccines in a large epidemiologic cohort.

Methods

A participant needed to complete an online survey and a blood draw to test for SARS-CoV-2 circulating plasma antibodies at four-time points spaced at least three months apart. Chronic disease predictors of vaccine non-response are evaluated using logistic regression with non-response as the outcome and each chronic disease + age as the predictors.

Results

As of April 24, 2023, 18,240 participants met the inclusion criteria; 0.58% (N = 105) of these are non-responders. Adjusting for age, our results show that participants with self-reported immunocompromised status, kidney disease, cancer, and “other” non-specified comorbidity were 15.43, 5.11, 2.59, and 3.13 times more likely to fail to mount a complete response to a vaccine, respectively. Furthermore, having two or more chronic diseases doubled the prevalence of non-response.

Conclusion

Consistent with smaller targeted studies, a large epidemiologic cohort bears the same conclusion and demonstrates immunocompromised, cancer, kidney disease, and the number of diseases are associated with vaccine non-response. This study suggests that those individuals, with chronic diseases with the potential to affect their immune system response, may need increased doses or repeated doses of COVID-19 vaccines to develop a protective antibody level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19SARS-CoV-2Antibodies, ViralHumansMaleFemaleMiddle AgedAdultAgedTexasChronic DiseaseSeroepidemiologic StudiesYoung AdultRisk Factors

Substanzen

COVID-19 VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • The University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, TX, United States of America.
  • The University of Texas Health Science Center at Houston, School of Public Health in Dallas, Dallas, TX, United States of America.
  • Center for Pediatric Population Health, UTHealth School of Public Health, Dallas, Texas, United States of America.
  • The University of Texas Health Science Center at Houston, School of Public Health in Brownville, Brownsville, TX, United States of America.
  • The University of Texas Health Science Center at Houston, School of Public Health in Austin, Austin, TX, United States of America.
  • University of Texas at Austin, Austin, TX, United States of America.

ORCID-Profile: Ashraf Yaseen, Yashar Talebi

Förderung

  • Texas Health and Human Services Commission

Zitieren

APA

Yaseen, A., DeSantis, S. M., Sabharwal, R., Talebi, Y., Swartz, M. D., Zhang, S., Leon Novelo, L., Pinzon-Gomez, C. L., Messiah, S. E., Valerio-Shewmaker, M., Kohl, H. W., Ross, J., Lakey, D., Shuford, J. A., Pont, S. J., & Boerwinkle, E. (2024). Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample. PLOS ONE. https://doi.org/10.1371/journal.pone.0303420

Vancouver

Yaseen A, DeSantis SM, Sabharwal R, Talebi Y, Swartz MD, Zhang S, et al. Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample. PLOS ONE. 2024. doi:10.1371/journal.pone.0303420

BibTeX
@article{Yaseen2024,
  author = {Yaseen, Ashraf and DeSantis, Stacia M and Sabharwal, Rachit and Talebi, Yashar and Swartz, Michael D and Zhang, Shiming and Leon Novelo, Luis and Pinzon-Gomez, Cesar L and Messiah, Sarah E and Valerio-Shewmaker, Melissa and Kohl, Harold W and Ross, Jessica and Lakey, David and Shuford, Jennifer A and Pont, Stephen J and Boerwinkle, Eric},
  title = {Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0303420}
}
Kostenlos starten →